Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now early-phase tilt small index

Upper Extremity Weakness: early-phase trial registry

1 of 2 indexed Upper Extremity Weakness trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #7,188 of 28,707 conditions by registered trial count.

2 US clinical trials · 1 currently recruiting · #7,188 of 28,707 conditions by registered trial count

Upper Extremity Weakness: 2 US clinical trials tracked, 1 recruiting.

Upper Extremity Weakness is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is University of Utah, running 1 of these trials.

Enrollment posture brief

Registry condition upper-extremity-weakness

OPEN 1 | RECR 50% | LATE 0 | EARLY 1 | RANK #7188 | SPON 1

Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Upper Extremity Weakness (th…50%
Open-enrollment share among volume-matched conditions near Upper Extremity Weakness

Upper Extremity Weakness lists 1 open slots (50% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Upper Extremity Weakness on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Upper Extremity Weakness is recruiting above its size-band peers.

    1 of 2 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 11

Phase Distribution

PhaseTrial count
Phase 1 1

Top Sponsors

Named interventions

Most-linked intervention names on Upper Extremity Weakness records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Placebo (for memantine) Drug
1 trials
Memantine XR Drug
1 trials
Low intensity focused ultrasound stimulation Device
1 trials

US sites by state

Facility locations filed on Upper Extremity Weakness trials. A trial with sites in several states counts in each.

Utah 1 trials
North Carolina 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Upper Extremity Weakness page

2 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 1 Upper Extremity Weakness trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • University of Utah sponsors the most Upper Extremity Weakness trials on record, review their full trial history before evaluating a specific study. See University of Utah's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Upper Extremity Weakness condition card totals 2 registered trials; most-linked intervention Placebo (for memantine); top US site state Utah. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.